Venkatesan Jay's Form 4 filing
Elicio Therapeutics, Inc. (ELTX) · filed Dec 17, 2021
- Accession no.
- 0001601485-21-000087
- Filed
- Dec 17, 2021
- Trade date
- Jun 24-Dec 15, 2021
- Filing delay
- 176 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $187.0K. It was filed 176 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Venkatesan JayCIK 0001413350 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2021 | Common Stock | FTax withholdingDisposed | −41,091 | $13.78 | −$566,233.98 | 1,239,257 | Direct | |
| Dec 15, 2021 | Common Stock | PPurchaseAcquired | +77,604 | $2.41 | +$187,025.64 | 1,316,861 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
President and Chief Executive Officer and Director